Episode #12: Trust in the Pharma Industry

In our twelfth episode of the Life Science Connect podcast series, we explore the public perception of trust in the pharma industry. We discuss the results from the research report Overcoming biopharma’s trust deficit: Why people mistrust the biopharma industry, as well as how COVID-19 has affected these perceptions and how the industry might improve diversity of clinical trials by improving trust.

Welcome to “Life Sciences Connect”, Deloitte’s Podcast on the Life Sciences industry. This series features conversations with leaders from across the Healthcare ecosystem sharing their insights on the critical issues facing the industry today.

In January 2021, Deloitte’s US and UK Centres for Health Solutions conducted consumer research in the US, UK, India and South Africa seeking to answer crucial questions around consumer trust in pharma, culminating in our research report Overcoming biopharma’s trust deficit: Why people mistrust the biopharma industry – and what to do about it. In today’s conversation, we are discussing how trust impacts biopharma and how companies can build and maintain consumer trust.

Life Sciences Connect

To see the full collections of episodes so far, please visit the Life Sciences Connect podcast library.